ZNA LI NEKO DA LI SU KANCEROGENE BONVIVA TABLETE

[maja-sa]

Da li neko ima konkretne informacije? Moja mama treba da pije te tablete ali sam cula da se prica da su kancerogene i da cak u nekim zemljama nisu dozvoljene. Zna li neko neki pozitivan primjer?

Hvala

[Pera Trta]

Vjerovatno misliš na BONIVA tablete.
Evo šta kažu na zvaničnoj stranici:

Carcinogenesis

In a 104-week carcinogenicity study, doses of 3, 7, or 15 mg/kg/day were administered by oral gavage to male and female Wistar rats (systemic exposures up to 12 and 7 times, respectively, human exposure at the recommended daily oral dose of 2.5 mg, and cumulative exposures up to 3.5 and 2 times, respectively, human exposure at the recommended once-monthly oral dose of 150 mg, based on AUC comparison). There were no significant drug-related tumor findings in male or female rats. In a 78-week carcinogenicity study, doses of 5, 20, or 40 mg/kg/day were administered by oral gavage to male and female NMRI mice (exposures up to 475 and 70 times, respectively, human exposure at the recommended daily oral dose of 2.5 mg and cumulative exposures up to 135 and 20 times, respectively, human exposure at the recommended once-monthly oral dose of 150 mg, based on AUC comparison). There were no significant drug-related tumor findings in male or female mice. In a 90-week carcinogenicity study, doses of 5, 20, or 80 mg/kg/day were administered in the drinking water to NMRI mice (cumulative monthly exposures in males and females up to 70 and 115 times, respectively, human exposure at the recommended dose of 150 mg, based on AUC comparison). A dose-related increased incidence of adrenal subcapsular adenoma/carcinoma was observed in female mice, which was statistically significant at 80 mg/kg/day (220 to 400 times human exposure at the recommended daily oral dose of 2.5 mg and 115 times human exposure at the recommended once-monthly oral dose of 150 mg, based on AUC comparison). The relevance of these findings to humans is unknown.

Ukratko, navode se tri studije na pacovima i miševima, kojima su davane višestruko veće doze od onih preporučenih ljudima. Dvije studije nisu pokazale vezu između lijeka i tumora, a samo u jednoj studiji došlo je do slučajeva raka nadbubrežne žlijezde kod mišica, kojima su davane doze 220-400 puta veće od onih koje koriste ljudi u preporučenim dnevnim dozama.

[maja-sa]

Hvala puno